{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T04:18:33Z","timestamp":1785730713571,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,5]],"date-time":"2027-01-05T00:00:00Z","timestamp":1799107200000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["HL094505"],"award-info":[{"award-number":["HL094505"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["HL169427"],"award-info":[{"award-number":["HL169427"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jtha.2025.09.023","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:30:18Z","timestamp":1760221818000},"page":"119-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ribosomal read through as an alternative therapy for patients with hemophilia with nonsense mutations"],"prefix":"10.1016","volume":"24","author":[{"given":"Zhigang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aabid","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7786-7580","authenticated-orcid":false,"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.09.023_bib1","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/jth.13443","article-title":"Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency","volume":"14","author":"Branchini","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.09.023_bib2","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3324\/haematol.2022.281279","article-title":"Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association","volume":"108","author":"Testa","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.09.023_bib3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-genom-091212-153527","article-title":"Therapeutics based on stop codon readthrough","volume":"15","author":"Keeling","year":"2014","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.jtha.2025.09.023_bib4","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1080\/13543784.2020.1828862","article-title":"ELX-02: an investigational read-through agent for the treatment of nonsense mutation-related genetic disease","volume":"29","author":"Kerem","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jtha.2025.09.023_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223954","article-title":"The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis","volume":"14","author":"Brasell","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2025.09.023_bib6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jcf.2021.01.009","article-title":"Targeting G542X CFTR nonsense alleles with ELX-02 restores CFTR function in human-derived intestinal organoids","volume":"20","author":"Crawford","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jtha.2025.09.023_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2025.09.023_bib8","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/s41467-022-30080-6","article-title":"Ataluren binds to multiple protein synthesis apparatus sites and competitively inhibits release factor-dependent termination","volume":"13","author":"Huang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2025.09.023_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.24332","article-title":"Ataluren treatment of patients with nonsense mutation dystrophinopathy","volume":"50","author":"Bushby","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jtha.2025.09.023_bib10","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","article-title":"Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"McDonald","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.09.023_bib11","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1007\/s00415-023-11687-1","article-title":"Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015-2022): 2022 interim analysis","volume":"270","author":"Mercuri","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.jtha.2025.09.023_bib12","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.3390\/ijms20123036","article-title":"Molecular mechanisms and determinants of innovative correction approaches in coagulation factor deficiencies","volume":"20","author":"Balestra","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2025.09.023_bib13","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1182\/blood-2005-03-1307","article-title":"Aminoglycoside suppression of nonsense mutations in severe hemophilia","volume":"106","author":"James","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.09.023_bib14","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.3324\/haematol.2018.205104","article-title":"Identification of candidate nonsense mutations of FVIII for ribosomal readthrough therapy","volume":"104","author":"Liu","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.09.023_bib15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3324\/haematol.2018.212118","article-title":"Variable readthrough responsiveness of nonsense mutations in hemophilia A","volume":"105","author":"Martorell","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.09.023_bib16","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1182\/blood-2016-09-738641","article-title":"Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations","volume":"129","author":"Branchini","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.09.023_bib17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/humu.23404","article-title":"Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B","volume":"39","author":"Ferrarese","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jtha.2025.09.023_bib18","doi-asserted-by":"crossref","first-page":"15394","DOI":"10.1073\/pnas.0610878104","article-title":"A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin","volume":"104","author":"Yang","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2025.09.023_bib19","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/s41467-020-15140-z","article-title":"2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations","volume":"11","author":"Trzaska","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2025.09.023_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187930","article-title":"Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases","volume":"12","author":"Benhabiles","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2025.09.023_bib21","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ymthe.2023.01.014","article-title":"Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis","volume":"31","author":"Leroy","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.jtha.2025.09.023_bib22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/biom15040458","article-title":"Cell-based small-molecule screening identifying proteostasis regulators enhancing factor VIII missense mutant secretion","volume":"15","author":"Srivastava","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.jtha.2025.09.023_bib23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/humu.22981","article-title":"HGVS recommendations for the description of sequence variants: 2016 update","volume":"37","author":"den Dunnen","year":"2016","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jtha.2025.09.023_bib24","article-title":"Missense mutations near the N-glycosylation site of the A2 domain lead to various intracellular trafficking defects in coagulation factor VIII","volume":"7","author":"Wei","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2025.09.023_bib25","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1016\/j.ymthe.2022.10.004","article-title":"Ectopic clotting factor VIII expression and misfolding in hepatocytes as a cause for hepatocellular carcinoma","volume":"30","author":"Kapelanski-Lamoureux","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.jtha.2025.09.023_bib26","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1182\/blood-2003-10-3591","article-title":"Bioengineering of coagulation factor VIII for improved secretion","author":"Miao","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.09.023_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101536","article-title":"A common human missense mutation of vesicle coat protein SEC23B leads to growth restriction and chronic pancreatitis in mice","volume":"298","author":"Wei","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.09.023_bib28","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/hmg\/ddx196","article-title":"Identification of the amino acids inserted during suppression of CFTR nonsense mutations and determination of their functional consequences","volume":"26","author":"Xue","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jtha.2025.09.023_bib29","doi-asserted-by":"crossref","first-page":"12508","DOI":"10.1073\/pnas.1605336113","article-title":"Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression","volume":"113","author":"Roy","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2025.09.023_bib30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/hae.13947","article-title":"The European Association for Haemophilia and Allied Disorders (EAHAD) coagulation factor variant databases: important resources for haemostasis clinicians and researchers","volume":"26","author":"McVey","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.09.023_bib31","doi-asserted-by":"crossref","first-page":"E2382","DOI":"10.1002\/humu.22247","article-title":"The CDC Hemophilia A Mutation Project (CHAMP) mutation list: a new online resource","volume":"34","author":"Payne","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jtha.2025.09.023_bib32","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1017\/S1355838200000716","article-title":"Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system","volume":"6","author":"Manuvakhova","year":"2000","journal-title":"RNA"},{"key":"10.1016\/j.jtha.2025.09.023_bib33","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1038\/s41467-024-46703-z","article-title":"Extended stop codon context predicts nonsense codon readthrough efficiency in human cells","volume":"15","author":"Mangkalaphiban","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2025.09.023_bib34","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52611","article-title":"Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides","volume":"9","author":"Wangen","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jtha.2025.09.023_bib35","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1182\/blood.V84.12.4214.bloodjournal84124214","article-title":"Role of the B domain for factor VIII and factor V expression and function","volume":"84","author":"Pittman","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.09.023_bib36","doi-asserted-by":"crossref","first-page":"18525","DOI":"10.1073\/pnas.0809677105","article-title":"Antioxidants reduce endoplasmic reticulum stress and improve protein secretion","volume":"105","author":"Malhotra","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2025.09.023_bib37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jtha.2023.10.007","article-title":"In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency","volume":"22","author":"Todaro","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.09.023_bib38","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.1093\/nar\/gku663","article-title":"New insights into the incorporation of natural suppressor tRNAs at stop codons in Saccharomyces cerevisiae","volume":"42","author":"Blanchet","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtha.2025.09.023_bib39","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3324\/haematol.12344","article-title":"Severe and moderate hemophilia A: identification of 38 new genetic alterations","volume":"93","author":"Casa\u00f1a","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.09.023_bib40","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1365-2516.2007.01487.x","article-title":"The molecular aetiology of haemophilia A in a New Zealand patient group","volume":"13","author":"Laurie","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.09.023_bib41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1538-7836.2011.04545.x","article-title":"Bioengineering of coagulation factor VIII for efficient expression through elimination of a dispensable disulfide loop","volume":"10","author":"Selvaraj","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.09.023_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001128","article-title":"Effect of correlated tRNA abundances on translation errors and evolution of codon usage bias","volume":"6","author":"Shah","year":"2010","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jtha.2025.09.023_bib43","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/ph17030314","article-title":"Readthrough activators and nonsense-mediated mRNA decay inhibitor molecules: real potential in many genetic diseases harboring premature termination codons","volume":"17","author":"Benslimane","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jtha.2025.09.023_bib44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1538-7836.2003.00013.x","article-title":"Analysis of the consequences of premature termination codons within factor VIII coding sequences","volume":"1","author":"David","year":"2003","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625006154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625006154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:50:44Z","timestamp":1773924644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625006154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1538783625006154"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.09.023","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ribosomal read through as an alternative therapy for patients with hemophilia with nonsense mutations","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}